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the diagnostic accuracy of MRA and location of nonpalpable testes (both for historical series and MRA series); the percentage of patients for whom testicular nubbin tissue would be left in situ (i.e. therefore being theoretically at risk of developing cancer); the estimated risk of having testicular tissue in a nubbin; the estimated risk of cancer occurring in an undescended testicle; and the risk of dying of cancer in patients with an uncorrected cryptorchid testis.
Study designs and other criteria for inclusion in the review
Not stated.
Sources searched to identify primary studies
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Nine studies appear to have been included in the review.
Methods of combining primary studies
The authors performed a meta-analysis based on two studies published in 1999 and 2001. They applied the results to a hypothetical series of patients using historical testicular localisation data (1992 -1996) . Data obtained from the other studies were presented in a narrative fashion.
Investigation of differences between primary studies
Results of the review
The meta-analysis of the two studies revealed that MRA was accurate in 98.5% of the patients (1.5% incorrect diagnosis), compared with 100% accuracy for laparoscopy.
The accuracy of MRA for nonpalpable testes varied depending on their location. Accuracy was 100% for abdominal, inguinal, inguinal nubbin and scrotal locations, and 0% for abdominal vanishing location.
The percentage of patients for whom testicular nubbin tissue would be left in situ would be 0% with the MRA-removal strategy, 29.1% with the MRA-observation strategy, and 0% with laparoscopy.
The estimated risk of having testicular tissue in a nubbin was 0 to 11%.
The estimated risk of cancer occurring in an undescended testicle was 3 to 10%.
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The risk of cancer in a testicular nubbin was 0 to 1.1%.
The risk of dying of cancer in patients with an uncorrected cryptorchid testis 5.9%.
Measure of benefits used in the economic analysis
The summary measure of health benefit appears to have been the number of children at risk of developing cancer or dying from cancer. The authors reported that this measure was estimated from data collected in the review by means of a "risk analysis".
Direct costs
The direct costs considered in the economic analysis appear to have been those of the hospital. The main resource use categories were hospital-related (operating room, surgical supplies, room and board, medications, intravenous fluids, radiographic studies and professional fees). The overall cost of each proposed treatment protocol algorithm was compared using data from a large paediatric hospital (Children's Medical Center Dallas) for a patient undergoing an uncomplicated surgery. In addition, actual data provided by the same institution, a published study (Lorenzo et al. 2004) and the 2002 Texas Medicare reimbursement rates were consulted for the estimation of costs. Discounting was not relevant since the costs were probably incurred during a short period of time, although this was not explicitly reported.
The unit costs were reported, but the price year was not explicit.
Statistical analysis of costs
The costs were treated deterministically. No statistical analysis of the costs was reported in the paper.
Indirect Costs
The indirect costs were not considered in the economic study.
Currency

US dollars ($).
Sensitivity analysis
One-way sensitivity analyses were conducted to evaluate the effect of varying individual probabilities and costs. Twoway sensitivity analyses were performed to evaluate the costs of care while varying operating room time and equipment costs. Neither the ranges nor the method of selecting the parameters and ranges were reported.
Estimated benefits used in the economic analysis
The highest estimated risk of cancer associated with the MRA-observation strategy was 1 in 300 children (0.32%). The highest associated risk of dying of cancer was 1 in 5,300 children (0.019%).
It could be inferred from the paper that with MRA-removal and laparoscopy there was an associated risk of cancer and of dying from cancer since no testicular nubbin tissue would be left in situ with these strategies.
Cost results
The average costs per child were:
$5,925 for a protocol of MRA with removal of nubbin tissue, $5,118 for a protocol of MRA with observation of nubbin tissue, and
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No incremental costs were reported.
Synthesis of costs and benefits
The costs and benefits were not combined.
Authors' conclusions
The use of magnetic resonance angiography (MRA) with observation of testicular nubbin tissue would result in 29% of patients avoiding surgery at a similar cost to standard care, without any significant increased risk of developing cancer of the testes. MRA followed by the removal of inguinal nubbins would dramatically reduce the number of operative interventions, but at increased costs.
CRD COMMENTARY -Selection of comparators
The reason for the choice of the comparator was clear, as diagnostic laparoscopy represents standard care. You should decide whether this represents standard care in your own setting.
Validity of estimate of measure of effectiveness
The analysis of effectiveness was based on data derived from the literature. The authors do not appear to have conducted a systematic review of the literature, and no details of the methods or conduct of the search and data extraction were provided. The authors did not report any information on the primary studies that provided the evidence. This point is important as if more studies had been included, the authors would have been able to conduct a receiver operating curve analysis to estimate the correlation between MRA sensitivity and specificity. The authors reported that the results of the review might have been affected by selection bias.
Validity of estimate of measure of benefit
The main benefit measure used in the economic analysis was the number of children at risk of developing cancer or dying from cancer. However, the results for MRA-removal and for laparoscopy were not explicitly reported and appear to have been based on assumptions. The authors did not report a generic measure of health benefit, such as qualityadjusted life-years, which would have enabled the study results to be compared with those for other interventions.
Validity of estimate of costs
